Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57:3169–3176. https://doi.org/10.2337/db08-1084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA (1994) Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283–287. https://doi.org/10.1016/S0140-6736(94)91336-6

Article  CAS  PubMed  Google Scholar 

Rickels MR, Peleckis AJ, Markmann E et al (2016) Long-term improvement in glucose control and counterregulation by islet transplantation for type 1 diabetes. J Clin Endocrinol Metab 101:4421–4430. https://doi.org/10.1210/jc.2016-1649

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodbard D (2016) Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther 18(Suppl 2):S3–S13. https://doi.org/10.1089/dia.2015.0417

Article  CAS  PubMed  Google Scholar 

Rickels MR, Peleckis AJ, Dalton-Bakes C et al (2018) Continuous glucose monitoring for hypoglycemia avoidance and glucose counterregulation in long-standing type 1 diabetes. J Clin Endocrinol Metab 103:105–114. https://doi.org/10.1210/jc.2017-01516

Article  PubMed  Google Scholar 

Flatt AJ, Peleckis AJ, Dalton-Bakes C et al (2023) Automated insulin delivery for hypoglycemia avoidance and glucose counterregulation in long-standing type 1 diabetes with hypoglycemia unawareness. Diabetes Technol Ther 25:302–314. https://doi.org/10.1089/dia.2022.0506

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seyed Ahmadi S, Westman K, Pivodic A et al (2020) The association between HbA1c and time in hypoglycemia during CGM and self-monitoring of blood glucose in people with type 1 diabetes and multiple daily insulin injections: a randomized clinical trial (GOLD-4). Diabetes Care 43:2017–2024. https://doi.org/10.2337/dc19-2606

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ólafsdóttir AF, Bolinder J, Heise T et al (2021) The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: an analysis based on the GOLD randomized trial (GOLD-5). Diabetes Obes Metab 23:619–630. https://doi.org/10.1111/dom.14257

Article  CAS  PubMed  Google Scholar 

Lin YK, Hung M, Sharma A et al (2019) Impaired awareness of hypoglycemia continues to be a risk factor for severe hypoglycemia despite the use of continuous glucose monitoring systems in type 1 diabetes. Endocr Pract 25:517–525. https://doi.org/10.4158/EP-2018-0527

Article  PubMed  PubMed Central  Google Scholar 

Lin YK, Richardson CR, Dobrin I et al (2022) Beliefs around hypoglycemia and their impacts on hypoglycemia outcomes in individuals with type 1 diabetes and high risks for hypoglycemia despite using advanced diabetes technologies. Diabetes Care 45:520–528. https://doi.org/10.2337/dc21-1285

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sherr JL, Laffel LM, Liu J et al (2024) Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey. Diabetes Care 47(6):941–947. https://doi.org/10.2337/dc23-1765

Article  PubMed  PubMed Central  Google Scholar 

Akturk HK, Dowd R, Shankar K, Derdzinski M (2021) Real-world evidence and glycemic improvement using Dexcom G6 features. Diabetes Technol Ther 23(Supplement 1):S21–S26. https://doi.org/10.1089/dia.2020.0654

Article  CAS  PubMed  Google Scholar 

Lin YK, Agni A, Chuisano S et al (2023) ‘You have to use everything and come to some equilibrium’: a qualitative study on hypoglycemia self-management in users of continuous glucose monitor with diverse hypoglycemia experiences. BMJ Open Diabetes Res Care 11:e003415. https://doi.org/10.1136/bmjdrc-2023-003415

Article  PubMed  PubMed Central  Google Scholar 

Lin YK, Hepworth E, de Zoysa N et al (2024) Relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes using continuous glucose monitoring systems. Diabetes Res Clin Pract 209:111596. https://doi.org/10.1016/j.diabres.2024.111596

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verhulst CEM, Fabricius TW, Teerenstra S et al (2022) Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review. Diabetologia 65:1601–1612. https://doi.org/10.1007/s00125-022-05749-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flatt AJ, Chen E, Peleckis AJ et al (2022) Evaluation of clinical metrics for identifying defective physiologic responses to hypoglycemia in long-standing type 1 diabetes. Diabetes Technol Ther 24:737–748. https://doi.org/10.1089/dia.2022.0103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gold AE, Macleod KM, Frier BM (1994) Frequency of severe hypoglycemia in patients with type i diabetes with impaired awareness of hypoglycemia. Diabetes Care 17:697–703. https://doi.org/10.2337/diacare.17.7.697

Article  CAS  PubMed  Google Scholar 

Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W (1995) Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18:517–522. https://doi.org/10.2337/diacare.18.4.517

Article  CAS  PubMed  Google Scholar 

Speight J, Barendse SM, Singh H et al (2016) Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q). Diabetic Med 33:376–385. https://doi.org/10.1111/dme.12824

Article  CAS  PubMed  Google Scholar 

US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, US Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79. https://doi.org/10.1186/1477-7525-4-79

Article  Google Scholar 

Little SA, Leelarathna L, Walkinshaw E et al (2014) Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 x 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 37:2114–2122. https://doi.org/10.2337/dc14-0030

Article  CAS  PubMed  Google Scholar 

Matus A, Flatt AJ, Peleckis AJ, Dalton-Bakes C, Riegel B, Rickels MR (2023) Validating and establishing a diagnostic threshold for the Hypoglycemia Awareness Questionnaire Impaired Awareness Subscale. Endocr Pract 29:762–769. https://doi.org/10.1016/j.eprac.2023.08.004

Article  PubMed  PubMed Central  Google Scholar 

Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA (2012) The T1D exchange clinic registry. J Clin Endocrinol Metab 97:4383–4389. https://doi.org/10.1210/jc.2012-1561

Article  CAS  PubMed  Google Scholar 

Foster NC, Beck RW, Miller KM et al (2019) State of type 1 diabetes management and outcomes from the T1D Exchange in 2016–2018. Diabetes Technol Ther 21:66–72. https://doi.org/10.1089/dia.2018.0384

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 4:e297. https://doi.org/10.1371/journal.pmed.0040297

Article  PubMed  PubMed Central  Google Scholar 

Sepúlveda E, Poínhos R, Nata G et al (2020) Differentiating hypoglycemia awareness status from hypoglycemia experience in tools for measuring impaired awareness of hypoglycemia. Diabetes Technol Ther 22:541–545. https://doi.org/10.1089/dia.2020.0034

Article  PubMed  PubMed Central  Google Scholar